Floatz logo

Voriconazole

Leukemia

Medical College of WisconsinSmall moleculePhase 3Dormant
B
56/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
65/ 100

Competitive context

125 Active assets in the Leukemia cohort.

Asset / SponsorPhaseRating
VINCRISTINE SULFATE
Inhye Ahn
Phase 3BB
FILGRASTIM
Hospital General de Mexico
Phase 4BB
MERCAPTOPURINE ANHYDROUS
Dana-Farber Cancer Institute
Phase 3BB
Idarubicine
Affiliated Hospital of Nantong University
Phase 3BB
Cyclophosphamide
National Cancer Institute (NCI)
Phase 4BB

View all 50 →

Same molecule, other indications

Voriconazole is also rated in:

infectious diseaseDormant
BB
Indicative ·
66 / 100
View asset →
fungal infectious diseaseDormant
B
Indicative ·
63 / 100
View asset →
acute myeloid leukemiaDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →